Unlinked Anonymous Monitoring of Human Immunodeficiency Virus Prevalence in High- and Low-risk Groups in Slovenia, 1993-2002

Croatian Medical Journal

Volumn 44, Issue 5, 2003, Pages 545-549

  Klavs, Irena ^a,b   Poljak, Mario ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Slovenia)

Author keywords

Confidentiality; HIV infections; HIV seroprevalence; HIV 1; Population surveillance; Risk factors; Slovenia

Indexed keywords

AGE; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HETEROSEXUALITY; HIGH RISK POPULATION; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MONITORING; PREGNANCY; PREVALENCE; RISK FACTOR; SALIVA LEVEL; SEX DIFFERENCE; SEXUALLY TRANSMITTED DISEASE; SLOVENIA; SYPHILIS;

CONFIDENTIALITY; FEMALE; HIV INFECTIONS; HIV SEROPREVALENCE; HOMOSEXUALITY, MALE; HUMANS; MALE; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; SLOVENIA; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0242612164     PISSN: 03539504     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Sutkin G, Chin J, Tarantola D, Mann J. Use of HIV surveillance data in national AIDS control programmes. Geneva: Global Programme on AIDS, World Health Organization; 1990.
2. World Health Organization. Unlinked anonymous screening for the public health surveillance of HIV infections (proposed international guidelines). Geneva: WHO; 1989.
3. Klavs I, Vidmar L, Glonar L. Epidemiology and natural history of HIV infection and AIDS [in Slovenian]. Zdrav Vestn 1990;59:125-30.
4. Klavs I. HIV infection and AIDS: global pandemic and epidemic in Slovenia [in Slovenian]. Zdravstveno Varstvo 1993;32:272-5.
5. EuroHIV. HIV/AIDS surveillance in Europe. End-year report 2002 (No. 68). Paris: Institute de Veille Sanitaire; 2003.
6. World Health Organization, Joint United Nations Programme on HIV/AIDS. Guidelines for second generation HIV surveillance. Geneva: UNAIDS/WHO; 2000.
7. Dondero TJ, Gill ON. Large-scale HIV serologic surveys: what has been learned? AIDS 1991;5 Suppl 2:S63-9.
8. PHLS AIDS Centre. The surveillance of HIV-1 infection and AIDS in England and Wales. CDR (Lond Engl Rev) 1991;1:R51-6.
9. Hull HF, Bettinger CJ, Gallaher MM, Keller NM, Wilson J, Mertz GJ. Comparison of HIV-antibody prevalence in patients consenting to and declining HIV-antibody testing in an STD clinic. JAMA 1988;260:935-8.
10. Wan L. The legality of unlinked anonymous screening for HIV infection: the U.S. approach. Health Policy 1990;14:29-35.
11. Bayer R, Lumey LH, Wan L. The American, British and Dutch responses to unlinked anonymous HIV seroprevalence studies: an international comparison. Law Med Health Care 1991;19:222-30.
12. Trišler Z, Seme K, Poljak M, Čelan-Lucu B, Sakoman S. Prevalence of hepatitis C and G virus infections among intravenous drug users in Slovenia and Croatia. Scand J Infect Dis 1999;31:33-5.
13. Poljak M, Bednarik J, Rednak K, Seme K, Kristančič L, Čelan-Lucu B. Seroprevalence of human T cell leukaemia/lymphoma virus type I (HTLV-I) in pregnant women, patients attending venereological outpatient services and intravenous drug users from Slovenia. Folia Biol (Praha) 1998;44:23-5.
14. Hamers F, Downs A. HIV in central and eastern Europe. Lancet 2003;361:1035-44.
15. Worm AM, Kvinesdal B. Human immunodeficiency virus surveillance at a sexually transmitted disease clinic in Copenhagen. Int J STD AIDS 1990;1:107-9.
16. Public Health Laboratory Service. Unlinked anonymous monitoring of HIV prevalence in England and Wales: 1990-92. Commun Dis Rep CDR Rev 1993;3: R1-11.
17. Tappin DM, Girdwood RW, Follett EA, Kennedy R, Brown AJ, Cockburn F. Prevalence of maternal HIV infection in Scotland based on unlinked anonymous testing of newborn babies. Update. Scott Med J 1993;38: 16-7.
18. Scott G, Goldberg D, Weir M, Cameron S, Peutherer J, Carrington D, et al. Prevalence of HIV-1 infection among heterosexual men and women attending genito-urinary clinics in Scotland: unlinked anonymous testing. BMJ 1997;315:1281-2.
19. Simms I, Rogers P, Catchpole M, McGarrigle CA, Nicoll A. Trends in undiagnosed HIV-1 infection among attenders at genitourinary medicine clinics, England, Wales, and Northern Ireland: 1990-6. Sex Transm Infect 1999;75:332-6.
20. Johnston J, Cameron S, Stewart M, Goldberg D, Fletcher C, Smyth W, et al. Unlinked anonymous HIV study of hospital patients and general practice attenders in Glasgow, 1991-1997. J Clin Pathol 2000;53:117-21.
21. Castilla J, Pachon I, Gonzalez MP, Amela C, Munoz L, Tello O, et al. Seroprevalence of HIV and HTLV in a representative sample of the Spanish population. Epidemiol Infect 2000;125:159-62.
22. Kessel AS, Watts CJ. Evaluation of the unlinked anonymous prevalence monitoring programme for HIV in England and Wales: science, ethics and health policy. Med Sci Monit 2001;7:1052-63.
23. Hamouda O. HIV/AIDS surveillance in Germany. J Acquir Immune Defic Syndr 2003;32 Suppl 1:49-54.
24. Mortimer JY. Saving tests by pooling sera - how great are the benefits? J Clin Pathol 1980;33:1120-1.
25. Cahoon-Young B, Chandler A, Livermore T, Gaudino J, Benjamin R. Sensitivity and specificity of pooled versus individual sera in a human immunodeficiency virus antibody prevalence study. J Clin Microbiol 1989;27: 1893-5.
26. Behets F, Bertozzi S, Kasali M, Kashamuka M, Atikala L, Brown C, et al. Successful use of pooled sera to determine HIV-1 seroprevalence in Zaire with development of cost-efficiency models. AIDS 1990;4:737-41.
27. Kline RL, Brothers TA, Brookmeyer R, Zeger S, Quinn TC. Evaluation of human immunodeficiency virus seroprevalence in population surveys using pooled sera. J Clin Microbiol 1989;27:1449-52.
28. Parry JV, Mahoney A, Mortimer PP. Are seroepidemiological surveys for human immunodeficiency virus infection based on test on pools of serum specimens accurate and cost-effective? Clin Diagn Virol 1993;1: 167-78.